SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-14-104539
Filing Date
2014-03-18
Accepted
2014-03-18 17:17:53
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d692251ds3.htm S-3 280506
2 EX-4.4 d692251dex44.htm EX-4.4 278906
3 EX-5.1 d692251dex51.htm EX-5.1 23451
4 EX-12.1 d692251dex121.htm EX-12.1 18355
5 EX-23.1 d692251dex231.htm EX-23.1 1915
6 EX-25.1 d692251dex251.htm EX-25.1 123915
7 GRAPHIC g692251ex5_1logo.jpg GRAPHIC 10655
8 GRAPHIC g692251ex5_1small.jpg GRAPHIC 6207
9 GRAPHIC g692251page_003.jpg GRAPHIC 32201
10 GRAPHIC g692251page_038.jpg GRAPHIC 32228
  Complete submission text file 0001193125-14-104539.txt   840613
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-194664 | Film No.: 14701857
SIC: 2834 Pharmaceutical Preparations